Drawing for CURASCRIPT CARES

USPTO serial 77752237

CURASCRIPT CARES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SMIGA, HOWARD
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CURASCRIPT CARES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay E. Cohen

LINDSAY E. COHEN BRYAN CAVE LLP211 N BROADWAY STE 3600SAINT LOUIS, MO 63102-2769UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services regarding healthcare costs; pharmacy services, namely, providing pharmaceutical benefit optimization guidance and advice; retail pharmacy services; prescription fulfillment services, namely, retail pharmacy services, mail-order pharmacy services, and order fulfillment of home infusion medications; wholesale distributorship services featuring pharmaceuticals to physicians, medical offices, and medical professionals; patient care management services, namely, pharmaceutical cost management; administration of pharmaceutical distribution services, namely, managing drug inventories for pharmacies; medical and health information services, namely, providing information and advice for patients, physicians, health plan administrators, and employers regarding controlling costs in managing health conditionsACTIVE—
036financial consulting services regarding healthcare costs; pharmacy benefit management services; consulting and advice services in the field of healthcare benefitsACTIVE—
041educational services, namely, conducting programs and training for patients, physicians, health plan administrators, and employers regarding diseases, treatment regimens, management of medical conditions, clinical assessment of medical conditions, minimization of the over-utilization of drugs, and controlling costs in managing health conditionsACTIVE—
044Health care services, namely, intense care management for patients; health care management services, namely, providing therapy specific management programs to patients using self-injectable medications and patients in therapy for treatment of diseases, psoriasis, bleeding disorders, respiratory syncytial virus, infertility, hepatitis, multiple sclerosis, growth hormone deficiency, rheumatoid arthritis, Human Immunodeficiency Virus, transplants, cancer, and pulmonary arterial hypertension; health care services, namely, medication and patient care disease management program that focuses on compliance and adherence to drug therapy for patients; medical and health information services, namely, providing information and advice for patients, physicians, health plan administrators, and employers regarding diseases, treatment regimens, management of medical conditions, clinical assessment of medical conditions, minimization of the over-utilization of drugs, and controlling costs in managing health conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 20, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 20, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 16, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 24, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2009NPUBNOTICE OF PUBLICATION—
Oct 16, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 16, 2009CNEAEXAMINERS AMENDMENT MAILED—
Oct 16, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 16, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Oct 16, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 15, 2009DOCKASSIGNED TO EXAMINER—
Oct 15, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 25, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 14, 2009ALIEASSIGNED TO LIE—
Sep 4, 2009CNEAEXAMINER'S AMENDMENT MAILED—
Sep 4, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 4, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Sep 4, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 4, 2009DOCKASSIGNED TO EXAMINER—
Jun 9, 2009MPMKNOTICE OF PSEUDO MARK MAILED—
Jun 8, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance